SLNO·834203309·US·equity·Healthcare - Biotechnology-13D/G
SLNO (SOLENO THERAPEUTICS INC) is held by 115 institutional investors as of Q1 2026. Largest holders: JANUS HENDERSON GROUP PLC ($237.6M), FMR LLC ($193.8M), WELLINGTON MANAGEMENT GROUP LLP ($148.2M). Net institutional sentiment: Mixed.
See how SLNO's score breaks down across 4 SEC sources
Showing 1-20 of 141
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer